Close
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
View All Publications - Ramon Cancino
Virtual Access to Subspecialty Care
Practice Transformation to Improve Cancer Screening Outcomes at an Academic Medical Center
Mays Cancer Center Partners with Nation’s Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States
Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO (Nov. 1, 2022) – Lung cancer is the leading cause of cancer death in the United States, accounting for almost 25% of […]
Professor and chair receives $1.5 million UT System Faculty STARs award to advance cancer drug development
Reuben S. Harris, PhD, professor and chair in the Department of Biochemistry and Structural Biology at the University of Texas Health Science Center at San Antonio (UT Health San Antonio), has received a UT System Faculty Science and Technology Acquisition and Retention (STARs) award in the amount of $1.5 million to establish his laboratory, assist […]
Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials
An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]